In addition, when compared to AD patients, these high-pathology non-demented individuals showed higher levels of neuroprotective ApoE and S100B, as well as angiogenic vascular endothelial growth factor (VEGF) [89]. This evidence concerns the gene APOE and Alzheimer disease.